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Abstract
Objective—To examine the relationship between trauma history, post-traumatic stress disorder
(PTSD), coping, and smoking in a diverse sample of pregnant women, some of whom are active
smokers.
Design—Secondary analysis from a prospective study on PTSD and pregnancy outcomes.
Setting—Maternity clinics at three health systems in the Midwestern United States.
Participants—Women age 18 or older (1,547) interviewed at gestational age less than 28 weeks.
Methods—Participants were classified at nonsmokers, quitters (stopped smoking during
pregnancy), and pregnancy smokers. Demographic, trauma, and pregnancy factors, substance use,
and use of tobacco to cope were compared across groups. Logistic regression assessed the
influence of these factors on being a smoker versus a nonsmoker and a quitter versus a pregnancy
smoker.
Results—Smokers differed from nonsmokers on all demographic risk factors (being African
American, being pregnant as a teen, having lower income and less education, and living in high-
crime areas), had higher rates of current and lifetime PTSD, and were more likely to report abuse
as their worst trauma. Pregnancy smokers had lower levels of education, were more likely to
classify their worst trauma as “extremely troubling,” and were more likely to exhibit PTSD
hyperarousal symptoms. In regression models, smoking “to cope with emotions and problems”
doubled the odds of continuing to smoke while pregnant even after accounting for several relevant
risk factors.
Conclusion—Smoking behavior in pregnancy may be influenced by the need to cope with
abuse-related PTSD symptoms. Clinicians should consider using trauma-informed interventions
when working with tobacco-using pregnant women.
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Maternal smoking behavior during pregnancy is known to have negative health
consequences for both the mother and child during the fetal and neonatal periods
(Cnattingius, 2004; Kleinman & Madans, 1985; Stein & Kline, 1983). Smoking can increase
the risks of infertility, ectopic pregnancy, placental abruption, placenta previa, preterm birth,
stillbirth and certain congenital malformations, and increase by 2–3 times the odds of
Sudden Infant Death Syndrome (Cnattingius). Relationships have been found between
maternal smoking and spontaneous abortion (Stein & Kline), and maternal smoking is
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among the most significant predictors of low birth weight, even after accounting for a
variety of socioeconomic stressors (Brooke, Anderson, Bland, Peacock, & Stewart, 1989).
However, despite the well-established ill-effects for both mother and fetus of smoking while
pregnant, many women continue to do so. The purpose of this article is to examine possible
influences on continuing to smoke during pregnancy in light of recent research on post-
traumatic stress disorder (PTSD) in pregnancy. Specifically, we consider the influences of
socioeconomic status (SES) risk factors, past trauma, and smoking “to cope with difficult
emotions or problems” on women’s tendency to continue smoking while pregnant.
Smoking in pregnancy
A number of factors influence the probability of continuing to smoke during pregnancy.
First, some addiction-related factors appear to play a role in mothers’ inability or
unwillingness to quit. For example, a history of heavy smoking, an early age at first use, and
exposure to second hand smoke all predict an inability to quit during pregnancy
(Cnattingius, 2004). Life stress-related factors also appear to play a role, with positive
correlations between smoking during pregnancy and having more children in the house, an
unplanned pregnancy, an unemployed partner, perceptions of more life stress, stressful life
events during pregnancy, and a perceived lack of control over life (Bullock, Mears,
Woodcock, & Record, 2001; Dejin-Karlsson et al., 1996). In addition, demographic factors
such as low socioeconomic status, low education, and a lack of social support are all
associated with continuing to smoke while pregnant (Bullock et al.).
The influence of post-traumatic stress disorder on smoking in the public
A psychological syndrome with physical manifestations, PTSD generally occurs following
exposure to an overwhelming trauma. The point prevalence of PTSD among women is
4.6%, with a lifetime prevalence of 12.3% (Resnick, Kilpatrick, Dansky, Saunders, & Best,
1993). In studies of non-pregnant samples (e.g., men and women), those with PTSD had a
fourfold increase in the odds of smoking (Breslau, Davis, & Shultz, 2003). Studies have
shown that 40%–60% of individuals with PTSD smoke, compared to approximately 20% of
the population in general (Beckham et al., 1997; Lasser et al., 2000). These smokers are also
more likely to be heavy smokers. A recent literature review by Feldner, Babson, and
Zvolensky (2007) concluded that exposure to trauma is associated with increased smoking
behavior, including smoking, smoking amount, and nicotine dependence, and that both
lifetime and current smoking rates are higher among individuals with lifetime or current
PTSD.
PTSD and pregnancy
Recent studies find a higher point prevalence of PTSD among pregnant women than women
from a national sample (Seng et al., 2010). Seng and colleagues (2009) found that women
with pre-existing PTSD report much higher numbers of symptoms of PTSD than women in
a similar but not pregnant sample. Therefore, it is likely exacerbation of PTSD accounts for
the higher prevalence during pregnancy. Women with abuse in their backgrounds are at
greatest risk for meeting diagnostic criteria prenatally (Seng et al., 2009). Studies of
pregnant sexual abuse survivors (Grimstad, Backe, Jacobsen, & Schei, 1998) and of
pregnant women with PTSD (Morland et al., 2007; Smith et al., 2006) have found
associations with tobacco and illicit drug use during pregnancy. However, while noting the
association between tobacco use and PTSD, these studies did not focus on tobacco use as a
principal outcome measure, nor take other related factors, such as the use of tobacco to cope,
into account.
Poor and minority women with PTSD during pregnancy have limited access to resources
that might facilitate quitting behavior. For example, they are less likely to have had mental
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health treatment (Seng, Kohn-Wood, McPherson, & Sperlich, in press) and are also less
likely to have social support from a partner or from their family of origin (Kruse, Kane Low,
& Seng, under review). Women enrolled in maternity care in low-resource settings also have
very high rates of PTSD (i.e., 13.9% in public sector clinics versus. 2.7% in private sector
clinics (Seng, Low, Sperlich, Ronis, & Liberzon, 2009)) that correspond to their relatively
higher rates of adverse perinatal and infant birth outcomes (Seng, Kane Low, Sperlich,
Ronis, & Liberzon, under review). Disadvantaged, PTSD-affected women who are pregnant
consequently may have more stressors and a greater PTSD symptom load with which to
cope while simultaneously having fewer resources to do so. This distress is likely coupled
with less access to pharmacologic mental health treatments (e.g., SSRIs), both due to income
levels (e.g., Kuno & Rothbard, 2005) and to the risks of using pharmacological treatment
during pregnancy (e.g., Einarson, Selby, & Koren, 2001).
Tobacco use to cope
Cigarette smoking may be used as a coping strategy or for mood control, especially among
women (Dejin-Karlsson et al., 1996; Edwards & Sims-Jones, 1998; Waldron, 1991), and is
often conceptualized as a form of self-medication among people with PTSD (Miller &
Guidry, 2001). Thus, among pregnant women in low-resource settings, post-traumatic stress
may be a particularly important factor to consider when attempting to reduce tobacco use.
Trauma-informed interventions may have greater potential for success than current smoking
cessation standards of care that do not consider tobacco use as a form of self-medication for
post-traumatic stress.
The purpose of this paper is to examine the relationships between demographic risk factors,
trauma, tobacco use, and coping in a diverse sample of pregnant women via a secondary
analysis. Researchers have noted relationships between tobacco and/or substance use and
PTSD, but did not consider 1) tobacco use as a specific outcome of interest or 2) differences
between those who quit and those who continue smoking while pregnant. We analyze
smoking behavior in relation to demographic risk factors, trauma history and PTSD,
pregnancy-related factors, prior and current mental health treatment, substance use, and
women’s disclosures that they use tobacco “to cope with emotions or problems.” This
information can be used to design targeted interventions for pregnant women with a history
of trauma who continue to smoke during pregnancy. Results could further inform clinicians
of the obstacles faced by these women as they attempt to change their smoking behaviors.
Data and Methods
Design and parent study description
This is a secondary analysis of a prospective three-cohort study of the effects of PTSD on
pregnancy outcomes (NIH NR008767, PI Seng). Data for this analysis are from the initial
survey interview conducted prior to 28 weeks gestation. Recruitment, procedures, and
instruments have been fully described elsewhere (Seng et al., 2009) and are briefly
summarized here.
Recruitment and interview procedures
In eight maternity clinics at three health systems in the Midwestern United States, obstetric
clinic nurses determined eligibility (age 18 or older, expecting a first infant, able to speak
English without an interpreter, and gestational age less than 28 weeks) from the new patient
history and invited eligible women to take part in a telephone survey about “stressful things
that happen to women, emotions, and pregnancy.” Interested women received a written
information document and gave contact information. A survey research organization
(DataStat, Ann Arbor, Michigan) conducted the interviews from August 2005 through
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October 2007. Interviews began by verifying eligibility and continued with a verbal
informed consent process, including explanation of the Confidentiality Certificate
protections. Institutional Review Board approvals were obtained from all three health
systems where recruitment took place. Professional research interviewers used a computer-
assisted telephone interview (CATI) program to conduct a standardized psychiatric
diagnostic interview designed for use with lay interviewers. Interviews lasted an average of
33 minutes. Participants who completed the interview were sent a $20 check by mail. A
computerized algorithm applied Diagnostic and Statistical Manual of Mental Disorders, 4th
Edition (DSM-IV; American Psychiatric Association, 1994) PTSD symptom diagnostic
criteria and assigned women to one of three cohorts for follow-up: PTSD-diagnosed
(lifetime, n = 319), trauma-exposed, but resilient controls (n = 380), and non-exposed
controls (n = 350). Women who did not fit these cohort definitions (n = 532), most of whom
had partial PTSD, were dismissed from follow-up, but their data are included in analyses of
this first interview, so this should be considered an unselected sample. The size of the
sample (n = 1,581) was determined based on power analysis and attrition estimates so that
clinical obstetric conditions of interest occurring at rates as low as 2% (e.g., hyperemesis
gravidarum) could be studied.
Organizing framework
The theoretical relationships we assess with our first logistic regression model (forthcoming)
posit that smoking is an outcome of abuse trauma and PTSD, especially among low-resource
women. In a second model, we posit that pregnancy smoking is an outcome of these factors
and may be additionally modified by pregnancy wantedness and by other substance use, and
that using tobacco to cope with emotions is a key explanatory factor.
Measures
Wherever possible the interview used established instruments. Trauma history was assessed
using the Life Stressor Checklist (LSC; Wolfe & Kimerling, 1997) which was modified for
use in a telephone format to assess 29 potentially traumatic events as occurring or not and
obtaining more in-depth information about the two worst (index) exposures, including age
and impact at the time and past-year impact. This measure is designed for use with women
and is considered the most sensitive measure of potentially traumatic events (Cusak, Falsetti,
& de Arellano, 2002). Lifetime and current (past month) PTSD symptoms and diagnosis
were obtained using the National Women’s Study PTSD module (Resnick et al., 1993), a
telephone interview used in the largest epidemiological study of PTSD in women, with high
sensitivity (sensitivity 0.99, specificity of 0.79) to PTSD when compared with the
established Structured Clinical Interview for DSM Disorders (SCID) (Kilpatrick et al.,
1994). Demographic information, pregnancy wantedness, and substance use data, including
information about quantity of cigarettes smoked and timing of cessation (if applicable), were
gathered using the Centers for Disease Control and Prevention Prenatal Risk Assessment
and Monitoring System (PRAMS) survey (Beck et al., 2002). Crime rate was considered an
aspect of sociodemographic status since this environmental factor is a known risk for PTSD.
This risk factor was coded as above or below the average U.S. crime rate based on statics
from the Federal Bureau of Investigation uniform crime report in 2000 and the woman’s zip
code (simplymaps.com, retrieved May 20, 2009). Two items included in this analysis were
generated for this survey. We asked about past and current (pregnancy) use of
psychotherapy and psychotropic medications and about use of twelve coping strategies
known to be used by women with PTSD to cope with symptoms. These strategies are
considered to reflect “engaged” and “disengaged” approaches (Rauch, Defever, Oetting,
Graham-Bermann, & Seng, in press). The stem for this set of queries related to alcohol,
tobacco, and illicit drugs asked, “Which, if any, of these ways have you ever used to cope
with emotions or problems?”
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Data reduction and smoking classification
Summary variables used in a previous study of PTSD and childbirth (Seng et al., 2008) are
used in this analysis and are briefly described here. Sociodemographic status is represented
using a six-level (0–5) index that is the sum of the following five risk factors for current
PTSD: young age (<21), African American race, poverty, low education (high school or
less), and living in a high crime rate zip code. Participants have been classified with regard
to their trauma history based on their “worst” (index) exposure into five trauma types:
family context trauma (e.g., not having enough money for food, family member jailed,
having been fostered or adopted, caretaking of sick relative, divorce, sudden, unexpected
death of a loved one), event trauma (e.g., being in an accident, disaster, or war zone),
reproductive trauma (characterized as “having a difficult time because of an abortion or
miscarriage” in this sample of nulliparous women), abuse trauma (lifetime sexual, physical,
or emotional abuse, or physical neglect), and “other” which was left unspecified. Finally,
participants were divided into one of three mutually exclusive smoking groups: Group 1:
Non-smokers, participants who reported no cigarette use before or during pregnancy (n =
1,159); Group 2: Quitters, participants who reported cigarette use before pregnancy, then
reported no cigarette use during pregnancy (n = 191); Group 3: Pregnancy smokers,
participants who reported any cigarette use during pregnancy (n = 197), including 11 women
who reported no smoking pre-pregnancy.
Analysis plan
Description of the sample was conducted by comparing smoking groups’ profiles on
demographic risk factors, trauma history and PTSD, pregnancy-related factors, prior and
current mental health treatment, substance use, and women’s disclosures that they use
tobacco “to cope with emotions or problems” using t-tests or one-way analysis of variance
(ANOVA) for interval-level variables and chi-square tests for nominal variables. Step-wise
logistic regression modeling was conducted to answer two primary research questions and
one post hoc question.
1. To what extent do trauma and PTSD predict ever being a smoker? Is this
moderated by sociodemographic status?
2. After controlling for sociodemographic status, trauma history, and PTSD, to what
extent does using tobacco as a strategy to cope with emotions and other pregnancy
factors (e.g., wantedness, other substance use) predict not being able to quit
smoking during pregnancy?
3. Do PTSD symptom clusters (intrusive re-experiencing, avoidance and emotional
numbing, and autonomic hyperarousal) differentially predict smoking during
pregnancy?
Results
Smoking classification
Thirty-four women (2%) had reported using tobacco to cope at some time, but did not report
whether they used tobacco in pregnancy and were hence unable to be classified as quitters or
pregnant smokers. They were removed from the analysis. Non-smokers (n = 1,159) were
75% of the sample. Non-smokers were contrasted with (ever, lifetime) smokers (n = 388,
25%) in some analyses. For other analyses, lifetime smokers were divided into quitters (n =
191, 12%) and pregnancy smokers (n = 197, 13%). In the tables comparing groups, statistics
were generated to compare non-smokers and smokers first, then to compare quitters and
pregnancy smokers.
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Demographics
Demographic risk factors were contrasted in Table 1. Table 1 shows a consistent pattern:
nonsmokers differed significantly from smokers on all demographic risk variables including
being African American, being pregnant as a teen, living in poverty, having a secondary
education or less, and living in high-crime areas. Non-smokers also had fewer SES risk
factors (1.6, SD = 1.8) than smokers (2.3, SD = 1.7). Pregnancy smokers were significantly
more like to have lower education (secondary education or less) than quitters (72% versus
58%).
Mental health and trauma history (Table 2)
Smokers had significantly higher rates of current PTSD (16% versus 6%) and lifetime PTSD
(current included; 32% versus 16%) than did nonsmokers. Likewise, pregnancy smokers had
significantly higher rates of both current (21% versus 11%) and lifetime (38% versus 28%)
PTSD compared to quitters. Smokers were more likely than nonsmokers to report abuse as
their worst trauma (24% versus 11%), and were more likely to report that their worst past-
year trauma was “extremely troubling” (19% versus 8%). Significantly more pregnancy
smokers than quitters likewise classified their worst trauma as extremely troubling (25%
versus 13%).
Pregnancy wantedness
Smokers differed from nonsmokers in the “wantedness” of their current pregnancies, with
more nonsmokers (52%) classifying their pregnancy as wanted “now” or “sooner” than
smokers (33%). There was no significant difference in pregnancy wantedness between
quitters and pregnancy smokers.
Treatment history
Overall, 17% of the sample had received mental health treatment or used prescription
medication at some point (not shown). Smokers differed significantly from nonsmokers in
their rates of treatment, with more smokers (23%) having received treatment prior to
pregnancy than nonsmokers (14%). Notably, no treatment differences exist during
pregnancy.
Drug use history (Table 3)
Participants were asked if they ever used “alcohol,” “tobacco,” or “marijuana, recreational
drugs or [abused] prescription drugs” (henceforth “other drugs”) “to cope with emotions or
problems.” Smokers differed from nonsmokers in both the percentage that used alcohol to
cope (26% versus 11%) and other drugs to cope (26% versus 5%). In addition, significantly
more pregnancy smokers had used tobacco to cope at some time than had quitters (69%
versus 50%). When questioned about any alcohol or drug use in pregnancy, significantly
more pregnancy smokers than quitters reported alcohol use (23% versus 13%) and other
drug use (16% versus 3%), revealing a strong possibility of polysubstance use among
pregnancy smokers.
Smoking prior to Pregnancy
To explore changes in smoking behavior possibly elicited by pregnancy, we analyzed the
differences in number of cigarettes smoked prior to and during pregnancy. Quitters smoked
a significantly different number of cigarettes before pregnancy than did pregnancy smokers
(p < .001; Table 4), with the majority of quitters (72%) smoking less than 10 cigarettes a
day, while the majority of pregnancy smokers (56%) smoked 10 cigarettes or more. Of note,
however, among pregnancy smokers, none reported smoking 20 or more cigarettes (down
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from 12%) during pregnancy, and 57% report smoking less than they did before they were
pregnant (not shown).
Regression Models
Three logistic regression models were used to understand the factors that increased the risk
of 1) being a smoker versus a nonsmoker and 2) continuing to smoke during pregnancy
versus successfully quitting. An additional model was used post-hoc to assess the affects of
PTSD symptom clusters (intrusive re-experiencing, avoidance and emotional numbing, and
autonomic hyperarousal) on inability to quit smoking during pregnancy.
The first logistic regression model (Table 5) considered in three steps the influence of the
sum of abuse traumas (step 1), lifetime prevalence of PTSD (inclusive of current PTSD)
(step 2), and the influence of cumulative sociodemographic risk factors (step 3), on the odds
of being a smoker, with nonsmokers as the reference group. The sum of abuse traumas was
significant at every step of the regression, with each additional instance of abuse increasing
the odds of being a smoker by 33% after all controls were entered in the model. Lifetime
PTSD likewise significantly increased the odds of being a smoker by 64%, even after
controlling for SES risk.
The second step-wise logistic regression model (Table 6) considered in five steps the
influence of the sum of abuse traumas (step 1), current PTSD, lifetime PTSD (exclusive of
current PTSD; step 2), whether a pregnancy was wanted, whether a patient’s worst trauma
was “extremely” troubling (step 3), use of tobacco to cope (step 4), and cumulative SES risk
factors (step 5) on the odds of quitting versus continuing to smoke during pregnancy.
The sum of abuse traumas fell from significance with the addition of the use of tobacco to
cope, which increased the odds of continuing to smoke while pregnant by 227%. Neither
current nor lifetime PTSD were significant, nor was wantedness of pregnancy or impact of
past trauma.
Because both lifetime and current PTSD significantly differed between quitters and pregnant
smokers, it was unexpected that PTSD would be reduced to non-significance when adding
covariates to the logistic regression models. Thus, we ran a third logistic regression model
(not shown) with PTSD separated into symptom clusters. After controlling for SES risk
factors and abuse trauma, each additional Cluster D symptom (hyperarousal) increased the
odds of continuing to smoke during pregnancy by 39%. The finding the Cluster D
symptomatology is associated with tobacco use has been seen before in samples of veterans
(Beckam 1997), but, to the best of our knowledge, has not been shown among pregnant
women.
Discussion
PTSD is associated with worse health outcomes generally, in part due to its association with
risk behaviors, including smoking. Previous perinatal studies have found associations
between an abuse history and smoking in pregnancy (Grimstad, Backe, Jacobsen, & Schei,
1998) and between PTSD and smoking in pregnancy (Morland et al., 2007; Smith et al.,
2006). This analysis extends knowledge by confirming that abuse history, PTSD—
especially hyperarousal symptoms—and low socioeconomic status contribute additively to
both being a smoker and to being unable to quit in pregnancy. The strongest predictor of
being unable to quit was disclosure that tobacco use functions for the woman as a way to
cope with emotions or problems, consistent with the theory that smoking may be a form of
self-medicating for the symptoms of PTSD (e.g., Miller & Guidry, 2001).
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Interpretation of the results of this analysis should take limitations into account. This is a
secondary analysis, so the information about smoking was limited, with a single item being
used to indicate that tobacco is being used to cope with emotions or problems. Since roughly
40% of smokers did not smoke “to cope with difficult emotions and problems,” there are
clearly other motivations for smoking that are not captured by this single item. Also, the
PTSD symptoms of hyper-arousal may or may not be considered “emotions” or problematic
by the participants. Future research should inquire about different motivations for smoking/
continuing to smoke while pregnant, perhaps using open-ended questions. Future studies
should also query explicitly the extent to which women smoke in response to memories of
traumatic events or other PTSD symptoms or distress. Pregnancy smoking is by self-report
via survey items in use for national perinatal risk assessment monitoring by the CDC, but
any self-report of such stigmatized behavior, especially in pregnancy, is likely under-
reported, potentially making our results an underestimation. Thus, future research should
include objective physiological indicators of recent smoking behavior (e.g. urinary cotinine
and baseline exhaled carbon monoxide; see Berkman, Dickinson, Falk, & Lieberman, in
press). Also, our sample includes only women expecting their first infant. Future research
should include women that have experienced childbirth previously, in order to investigate
possible differences in coping strategies and effects of trauma in larger households.
There are strengths as well. This is a large, diverse sample. It includes women from both
public- and private-sector prenatal clinics, making the findings more generalizable. Trauma
history and mental health status were measured with well-established epidemiologic
interviews. And, although the single item inquiry of smoking to cope is not an exhaustive
list of possible motivations, it was predictive of continued smoking in pregnancy and
correlated with higher rates of PTSD. Thus, it could serve as a starting point for the
development of a screening tool to be used when working with pregnant women.
There are several implications for research. Qualitative study is warranted to help verify the
self-medicating theory of tobacco use and to elucidate details about barriers to quitting that
are related to trauma history, PTSD, and lack of coping resources, especially among
pregnant women. Biological research is needed to elucidate the pathways by which nicotine
may be soothing to PTSD symptoms in general, and symptoms of autonomic hyperarousal
specifically. Recent development in experience sampling and ecological momentary
assessment in difficult to reach populations (Galloway, Didier, Garrison, & Mendelson,
2008; Kimhy et al., 2009), ecological hormone collection (Seng et al., 2008), and innovative
uses of technology among substance users and smokers (Berkman, Dickenson, Falk, &
Lieberman, in press) could easily be adapted to samples of pregnant smokers and could
provide invaluable data about the daily lives and influences that contribute to continued
smoking and drug use in this population.
Intervention studies of medications for PTSD would contribute knowledge if they also
assessed the impact of the medication on smoking behavior. Such data would inform the
benefit and risk assessment undertaken when counseling pregnant women about
pharmacotherapy for PTSD. It is possible that the risks to both mother and fetus from
medication are less than those associated with nicotine. Finally, intervention research is
urgently needed to compare the effectiveness of trauma-informed treatment for tobacco
addiction with standard smoking cessation programs for pregnant women; addressing the
dynamic processes of smoking as an effort to soothe hyperarousal and as an addiction may
yield better results.
Nurses, nurse practitioners, midwives, and physicians can use the results of this study to
improve their interactions with pregnant clients who have not been able to quit smoking by
the time they enter prenatal care. Specifically, we advocate for an increase in trauma-
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informed intervention as defined by the Substance Abuse and Mental Health Services
Administration (SAMHSA). We believe that trauma-informed care, or care that is “modified
to include a basic understanding of how trauma affects the life of an individual seeking
services,” (SAMHSA, n.d.) could be beneficial for professionals who work with pregnant
women. Trauma-informed treatment can recognize the co-occurrence of pregnancy and
smoking as an indication of a history of trauma, and work with or refer the client
accordingly. Acknowledging the role of traumatic stress as a trigger for smoking, and
assessing whether this dynamic fits the client, may further improve the working alliance.
Conclusion
Forty percent of women who are smoking in pregnancy have had lifetime PTSD, and 20%
meet full diagnostic criteria in pregnancy. Pregnancy is a window of opportunity to have a
strong impact on health behaviors because it is a time in a woman’s life where she is
particularly motivated to be healthy and has frequent contact with health care professionals
who can support her efforts to decrease risk behaviors. For abuse survivors with PTSD,
addressing the link between smoking and traumatic stress may lead to better cessation rates,
better pregnancy outcomes, and better health across her lifespan. Lastly, given that a number
of negative health effects for the fetus have proven dose-response relationships with
smoking (e.g., preterm birth, still birth) and that women tend to reduce their cigarette use
during pregnancy, smoking reduction, not just cessation, is a useful target when working
with women who smoke during pregnancy.
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